CAT# | CPM-1-0456 |
Sequence | GLQHWVPEL |
Size | 50 Test, 100 Test | Antigen | Cancer | Epitope Origin | BA46 | MHC Restriction | HLA-A_02_01 | Conjugate | BV421 |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0539 | HLA-A_24_02 HCV E2 717-725 tetramer-EYVLLLFLL-APC labeled | Inquiry | ||
CPM-1-0570 | HLA-A_02_01 BTG1 tetramer-TLWVDPYEV-PE labeled | Inquiry | ||
CPM-1-0308 | HLA-A_02_01 p53 tetramer-KLCPVQLWV-APC labeled | Inquiry | ||
CPM-1-0746 | HLA-B_07_02 Hsp27 tetramer-APAYSRAL-PE labeled | Inquiry | ||
CPM-1-0640 | HLA-A_02_01 MAGE-A2 tetramer-YLQLVFGIEV-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
PM102 is a novel synthetic peptide that effectively reverses the anticoagulant effect of heparin. It can be used ...
Dynorphin A (1-13) [Dyn-A (1-13)] is a short-chain polypeptide containing 13 amino acids and having extensive bi ...
PMX-53, a chemically synthesized peptide material, is a potent C5a antagonist in human neutrophils and macrophag ...
Figure 1. Chemical structure of lysipressinLysipressin ([Lys8]-vasopressin) has been identified in the North Ame ...
Discovery and Structure Calcitonin, also called thyrocalcitonin, a protein hormone synthesized and secreted in humans and oth ...